Clinical Trial Update: Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

View source ↗

Summary

A clinical trial is investigating whether posttranslationally modified Fetuin-A in urine can serve as a biomarker of renal dysfunction in patients with chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: University Hospital, Martin | Conditions: Transplant Recipient (Kidney), Primary Kidney Transplantation | Status: ENROLLING_BY_INVITATION